Dalton Pharma Services Email Format
Pharmaceutical ManufacturingOntario, Canada51-200 Employees
Dalton Pharma Services operates as a contract pharmaceutical manufacturer offering end-to-end chemistry development and production services to biotechnology and pharmaceutical clients worldwide. The company runs a 42,000-square-foot facility in North York, Ontario, capable of manufacturing active pharmaceutical ingredients, sterile injectables, finished drug products in vials or syringes, and solid oral dosage forms. API production spans gram to kilogram scales, including sterile APIs. Its capabilities extend through all stages of the regulatory process, from early Phase I studies to commercial production, supported by development work in chemistry and process development, medicinal chemistry, drug conjugation and targeted delivery, analytical method development and validation, stability testing, formulation, and polymorphism screening, complemented by a catalog of about 2,500 reference standards, building blocks, metabolites, and impurities via the Dalton Research Molecules division. In March 2026, Dalton announced the launch of the RoboFil system to expand aseptic fill-finish capacity in Toronto.